Analysis Zhong Yuan Bio-Technology Holdings Limited (ZHYBF)
5/30/2024
Analysis of Zhong Yuan Bio-Technology Holdings Limited (ZHYBF)
Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) has shown a consistent uptrend in its stock price over the past few days. The Relative Strength Index (RSI) indicates a bullish momentum, with a value above 50, suggesting a potential continuation of the upward movement.The Moving Average Convergence Divergence (MACD) indicator also supports the bullish sentiment, with the MACD line above the signal line and a positive MACD histogram, indicating a strengthening bullish trend.
In terms of moving averages, the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) are all showing an upward trend, further supporting the bullish outlook for ZHYBF.
Overall, based on the technical indicators, ZHYBF appears to be in a strong bullish trend, and investors may consider this stock for potential long positions. However, it is always recommended to conduct thorough research and consider other factors before making any investment decisions.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided at this time. The previous results were reported on February 27, 2025, through the Transfer Agent. Before that, on January 31, 2025, the results were released after hours. The results for October 31, 2024, were not provided at the time. On August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The company's financials show a strong cash flow, with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet indicates a total cash of $67.15 billion and total debt of $104.59 billion, resulting in a current ratio of 1.037. The company's book value per share is $4.837, total cash per share is $4.379, and total debt to equity ratio is 140.968.In terms of profitability, the company has a profit margin of 26.31% and an operating margin of 30.74%. The return on assets is 22.07% and the return on equity is 147.25%. The fiscal year ends on September 30, 2023, with the most recent quarter ending on March 31, 2024.
The income statement shows an EBITDA of $131.39 billion, revenue of $381.62 billion, and net income to common of $100.39 billion. The diluted EPS is $6.43, gross profit is $169.14 billion, revenue per share is $24.54, with a quarterly revenue growth of -4.3% and quarterly earnings growth year-over-year of -2.2%.
In terms of stock statistics, the company has a short ratio of 1.53, with 99.29 million shares shorted out of 15.31 billion float shares. The shares outstanding are 15.33 billion, with 5.22% held by insiders and 57.59% held by institutions. The short percent of shares outstanding is 0.65%.
Valuation metrics show a PEG ratio of 26.32, forward PE of 26.32, and trailing PE of 29.59. The enterprise value is $2.95 trillion, with a price to book ratio of 39.34, price to sales ratio of 7.65, enterprise to EBITDA of 22.76, and enterprise to revenue of 7.73. The market capitalization is $2.92 trillion.
The stock price summary includes a beta of 1.264, with a 50-day moving average of $176.26 and a 200-day moving average of $181.04. The fifty-two-week low is $164.08, the high is $199.62, and the change is 6.85%.
In terms of dividends and splits, the company has a payout ratio of 14.93% and a forward annual dividend rate of 1. The dividend date is May 16, 2024, with an ex-dividend date of May 10, 2024. The last split date was on August 31, 2020, with a 4-for-1 split. The 5-year average dividend yield is 0.73%, with a forward annual dividend yield of 0.53% and a trailing annual dividend yield of 0.51%.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have shown an increasing trend, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has shown an increasing trend, with the highest value in 2018 at $107,147,000,000.
6. The company has been relying more on non-current assets to support its operations.
7. There has been a consistent increase in retained earnings over the years.
8. The company has been managing its short-term debt effectively, as it has not shown a significant increase over the years.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. Financing activities show significant fluctuations, with large amounts being spent on common stock repurchase and debt issuance/payment.
4. Investing activities also vary, with notable amounts spent on the sale and purchase of investments.
5. The end cash position has been fluctuating, but overall, the company has maintained a healthy cash reserve.
6. Interest paid and income tax paid figures show variations, impacting the overall cash flow position.
7. Stock-based compensation has been a significant factor in the company's financial activities.
8. The company has been paying dividends consistently, affecting its financing cash flow.
9. The company's net income has been relatively stable, with some fluctuations over the years.
10. The company's cash flow statement reflects a mix of strategic investments, operational performance, and financial management decisions.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.33, with a low estimate of $1.27 and a high estimate of $1.36. This shows growth compared to the EPS of $1.26 from a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.53, with a low estimate of $1.44 and a high estimate of $1.63. This also indicates growth compared to the EPS of $1.46 from a year ago.
3. For the current year ending on September 30, 2024, the average EPS estimate is $6.59, with a low estimate of $6.43 and a high estimate of $6.92. This demonstrates an increase from the EPS of $6.13 from the previous year.
4. Looking ahead to the next year ending on September 30, 2025, the average EPS estimate is $7.23, with a low estimate of $6.40 and a high estimate of $7.90. This forecast suggests further growth compared to the EPS of $6.59 from the previous year.
Overall, the analysts' estimates point towards a positive outlook for the company's earnings per share, showing a trend of growth in both the quarterly and annual figures.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, the following conclusions can be drawn:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth rates expected in the upcoming fiscal year.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average growth rate for the past 5 years is 20.1% per annum.
6. Next 5 Years (per annum): The estimated growth rate for the next 5 years is 11% per annum.
These estimates suggest that the company has experienced significant growth in the past but is expected to see a more moderate growth rate in the coming years, with a slight increase in the next year compared to the current year.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a wide range of opinions on the future price of the security, with the low end at $164, the high end at $250, and the average at $202.26. The current price of the security is $191.57, which is below the median and average forecasted prices. Investors should consider these forecasts along with other factors when making investment decisions.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential need for cost management.
3. The gross profit margin has remained relatively stable over the years, indicating efficient cost control measures.
4. Operating income has shown a positive trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
5. Net income has also been increasing consistently, from $57.4 billion in 2020 to $97 billion in 2023.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally been on an upward trajectory.
7. The company has been able to maintain a healthy EBITDA margin, indicating strong operational performance.
8. Overall, the financial performance of the company in terms of revenue and profitability has been positive and improving over the years.
MACD of ZHYBF
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
